BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 1387926)

  • 1. Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists.
    Tyers MB; Freeman AJ
    Oncology; 1992; 49(4):263-8. PubMed ID: 1387926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of 5-HT3 receptor antagonists and anti-emetic mechanisms of action.
    Freeman AJ; Cunningham KT; Tyers MB
    Anticancer Drugs; 1992 Apr; 3(2):79-85. PubMed ID: 1525396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
    Tsukagoshi S; Ohta J; Taguchi T
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and anti-emetic properties of ondansetron.
    Tyers MB; Bunce KT; Humphrey PP
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S15-9. PubMed ID: 2533894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic mediation of vomiting.
    Gale JD
    J Pediatr Gastroenterol Nutr; 1995; 21 Suppl 1():S22-8. PubMed ID: 8708863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serotonin and anticancer drug-induced emesis].
    Minami M; Endo T; Hamaue N; Hirafuji M
    Yakugaku Zasshi; 2004 Aug; 124(8):491-507. PubMed ID: 15297719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and preclinical antiemetic properties of ondansetron.
    Tyers MB
    Semin Oncol; 1992 Aug; 19(4 Suppl 10):1-8. PubMed ID: 1387245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms by which cancer chemotherapeutic drugs induce emesis.
    Cubeddu LX
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):2-13. PubMed ID: 1485177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of serotonin in emesis].
    Minami M; Endo T; Hirafuji M
    Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):233-42. PubMed ID: 8974084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacology of emesis in relation to clinical response.
    Costall B; Naylor RJ
    Br J Cancer Suppl; 1992 Dec; 19():S2-7; discussion S7-8. PubMed ID: 1467196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin mechanisms in chemotherapy-induced emesis in cancer patients.
    Cubeddu LX
    Oncology; 1996 Jun; 53 Suppl 1():18-25. PubMed ID: 8692546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
    Endo T; Sugawara J; Nemoto M; Minami M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):227-39. PubMed ID: 10342910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emesis and anti-emesis.
    Naylor RJ; Rudd JA
    Cancer Surv; 1994; 21():117-35. PubMed ID: 8564988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis.
    Lindley C; Blower P
    Am J Health Syst Pharm; 2000 Sep; 57(18):1685-97. PubMed ID: 11006796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-emetic activity of GK-128 in Suncus murinus.
    Ito C; Isobe Y; Kijima H; Kiuchi Y; Ohtsuki H; Kawamura R; Tsuchida K; Higuchi S
    Eur J Pharmacol; 1995 Oct; 285(1):37-43. PubMed ID: 8846809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B
    Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vomiting reflex and the role of 5-HT3 receptors.
    Freeman AJ; Bountra C; Dale TJ; Gardner CJ; Twissell DJ
    Anticancer Drugs; 1993 Dec; 4 Suppl 2():9-15. PubMed ID: 7511008
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of ondansetron.
    Naylor RJ; Rudd JA
    Eur J Anaesthesiol Suppl; 1992 Nov; 6():3-10. PubMed ID: 1425623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology].
    d'Allens H; Aubert B; Bons J; Pappo M
    Bull Cancer; 1991; 78(12):1139-46. PubMed ID: 1838490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.